Mannkind Corp (MNKD): Next-Year EPS Estimate 914.29%
As of 2026-06-04, Mannkind Corp (MNKD) has a next-year EPS growth estimate of 914.29%.
MNKD was first flagged by our screen on 2026-05-31, when analyst consensus for its next-year EPS growth was revised from 800.00% to 938.66%. Current-year growth is projected at -187.50%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 914.29%
- EPS growth this year
- -187.50%
- EPS next quarter (est)
- -$0.01
- Last price
- $3.52
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 914.29% | -187.50% | -$0.01 | $3.52 |
| 2026-06-03 | 914.29% | -187.50% | -$0.01 | $3.36 |
| 2026-06-02 | 914.29% | -187.50% | -$0.01 | $3.43 |
| 2026-06-01 | 914.29% | -187.50% | -$0.01 | $3.53 |
| 2026-05-31 | 938.66% | -184.88% | -$0.01 | $3.77 |
| 2026-05-28 | 800.00% | -200.00% | -$0.01 | $3.64 |
| 2026-05-27 | 800.00% | -200.00% | -$0.01 | $3.55 |
| 2026-05-26 | 800.00% | -200.00% | -$0.01 | $3.53 |
| 2026-05-25 | 800.00% | -200.00% | -$0.01 | $3.38 |
| 2026-05-24 | 800.00% | -200.00% | -$0.01 | $3.38 |
| 2026-05-21 | 800.00% | -200.00% | -$0.01 | $3.31 |
| 2026-05-20 | 800.00% | -200.00% | -$0.01 | $3.25 |
| 2026-05-19 | 800.00% | -200.00% | -$0.01 | $2.96 |
| 2026-05-18 | 800.00% | -200.00% | -$0.01 | $2.99 |
| 2026-05-17 | 800.00% | -200.00% | -$0.01 | $3.09 |
| 2026-05-14 | 800.00% | -200.00% | -$0.01 | $3.22 |
| 2026-05-13 | 800.00% | -200.00% | -$0.01 | $3.22 |
| 2026-05-12 | 800.00% | -200.00% | -$0.01 | $3.28 |
| 2026-05-11 | 800.00% | -200.00% | -$0.01 | $3.36 |
| 2026-05-10 | 800.00% | -200.00% | -$0.01 | $3.52 |
| 2026-05-07 | 1900.00% | -137.50% | $0.00 | $3.55 |
| 2026-05-06 | 546.15% | -18.75% | $0.00 | $3.56 |
| 2026-05-05 | 546.15% | -18.75% | $0.00 | $2.86 |
| 2026-05-04 | 546.15% | -18.75% | $0.00 | $2.81 |
| 2026-05-03 | 546.15% | -18.75% | $0.00 | $2.84 |
| 2026-04-30 | 546.15% | -18.75% | $0.00 | $2.83 |
| 2026-04-29 | 546.15% | -18.75% | $0.00 | $2.75 |
| 2026-04-28 | 546.15% | -18.75% | $0.00 | $2.79 |
| 2026-04-27 | 565.49% | -13.56% | $0.00 | $2.63 |
| 2026-04-26 | 565.49% | -13.56% | $0.00 | $2.70 |
Recent News
- MNKD Stock Jumps On Receiving FDA Approval For Afrezza To Treat Diabetes In ChildrenStocktwits
- MannKind to Host Conference Call Today to Discuss Afrezza Pediatric ApprovalGlobeNewswire
- MannKind Announces FDA Approval of Afrezza, the First and Only Inhaled Mealtime Insulin for Use in Children and Adolescents Aged 6 and Older Living with DiabetesGlobeNewswire
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Mannkind Corp's next-year EPS growth estimate?▾
As of 2026-06-04, Mannkind Corp (MNKD) has a next-year EPS growth estimate of 914.29%, based on analyst consensus.
When was the latest EPS estimate revision for MNKD?▾
The most recent revision occurred on 2026-06-01, when analysts adjusted the next-year EPS growth estimate from 938.66% to 914.29%.
What sector and industry does Mannkind Corp belong to?▾
Mannkind Corp operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. MNKD appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Mannkind Corp (MNKD) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports